Daiichi Sankyo brings Glycotope antibody in-house for $132.5M
Daiichi Sankyo is spending $132.5 million to buy an antibody outright that it had already licensed from Glycotope. The one-off fee “satisfies” all milestone and
Daiichi Sankyo is spending $132.5 million to buy an antibody outright that it had already licensed from Glycotope. The one-off fee “satisfies” all milestone and
We just wrapped day 2 of JPM. We’ve been paying close attention to news about the industry’s biggest drugmakers. Jaimy Lee had a Sign up
Medical experts from around the globe proposed a more nuanced approach to diagnosing obesity that does not rely exclusively on body mass index (BMI) alone.
Hemmige is an infectious disease specialist. In late November, HHS issued a final rule updating transplant regulations to enable every U.S. transplant center to transplant
The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of acquisition, earning more than $7.3 billion in
The FDA issued a proposed rule Tuesday that would require food manufacturers to put “Nutrition Info” labels on the front of their packages stating whether
While many adolescents and young adults (AYA) with cancer died in their preferred locations, about 30% who wanted to die at home were unable to
Sana Biotechnology said a type 1 diabetes (T1D) patient received an allogeneic primary islet cell transplantation without immunosuppression. The company’s engineered cell product (UP421) uses
Welcome to “Ask the Program Director,” a column from MedPage Today where your most pressing questions about residency — from the application process to life
Higher consumption of green tea, but not coffee, was associated with fewer cerebral white matter lesions in prospective studies of aging in Japan. (npj Science